Jul 18, 2024, 00:18
Joshua Brody: Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared on X:
“Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma with 85% complete remission rate… with thanks to the patients, families, and clinical research team at Mount Sinai Health System and around the world.”
Read further.
Source: Joshua Brody/X
Jul 17, 2024, 23:37